Insomnia in central neurologic diseases--occurrence and management

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Insomnia in central neurologic diseases--occurrence and management. / Mayer, Geert; Jennum, Poul; Riemann, Dieter; Dauvilliers, Yves.

In: Sleep Medicine Reviews, Vol. 15, No. 6, 2011, p. 369-78.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Mayer, G, Jennum, P, Riemann, D & Dauvilliers, Y 2011, 'Insomnia in central neurologic diseases--occurrence and management', Sleep Medicine Reviews, vol. 15, no. 6, pp. 369-78. https://doi.org/10.1016/j.smrv.2011.01.005

APA

Mayer, G., Jennum, P., Riemann, D., & Dauvilliers, Y. (2011). Insomnia in central neurologic diseases--occurrence and management. Sleep Medicine Reviews, 15(6), 369-78. https://doi.org/10.1016/j.smrv.2011.01.005

Vancouver

Mayer G, Jennum P, Riemann D, Dauvilliers Y. Insomnia in central neurologic diseases--occurrence and management. Sleep Medicine Reviews. 2011;15(6):369-78. https://doi.org/10.1016/j.smrv.2011.01.005

Author

Mayer, Geert ; Jennum, Poul ; Riemann, Dieter ; Dauvilliers, Yves. / Insomnia in central neurologic diseases--occurrence and management. In: Sleep Medicine Reviews. 2011 ; Vol. 15, No. 6. pp. 369-78.

Bibtex

@article{96286e6c43304c49950f2b5a547669b8,
title = "Insomnia in central neurologic diseases--occurrence and management",
abstract = "The objective of this review is to highlight the impact of insomnia in central neurological disorders by providing information on its prevalence and give recommendations for diagnosis and treatment. Insomnia in neurological disorders is a frequent, but underestimated symptom. Its occurrence may be a direct consequence of the disease itself or may be secondary to pain, depression, other sleep disorders or the effects of medications. Insomnia can have a significant impact on the patient's cognitive and physical function and may be associated with psychological distress and depression. Diagnosis of insomnia is primarily based on medical history and validated questionnaires. Actigraphy is a helpful diagnostic tool for assessing the circadian sleep-wake rhythm. For differential diagnosis and to measure the duration of sleep full polysomnography may be recommended. Prior to initiating treatment the cause of insomnia must be clearly identified. First line treatment aims at the underlying neurologic disease. The few high quality treatment studies show that short term treatment with hypnotics may be recommended in most disorders after having ruled out high risk for adverse effects. Sedating antidepressants may be an effective treatment for insomnia in stroke and Parkinson's disease (PD) patients. Melatonin and light treatment can stabilize the sleep-wake circadian rhythm and shorten sleep latency in dementias and PD. Cognitive behavioral therapy (CBT) can be effective in treating insomnia symptoms associated with most of the central neurological diseases. The prevalence and treatment of insomnia in neurological diseases still need to be studied in larger patient groups with randomized clinical trials to a) better understand their impact and causal relationship and b) to develop and improve specific evidence-based treatment strategies.",
author = "Geert Mayer and Poul Jennum and Dieter Riemann and Yves Dauvilliers",
note = "Copyright {\textcopyright} 2011 Elsevier Ltd. All rights reserved.",
year = "2011",
doi = "10.1016/j.smrv.2011.01.005",
language = "English",
volume = "15",
pages = "369--78",
journal = "Sleep Medicine Reviews",
issn = "1087-0792",
publisher = "Elsevier Masson",
number = "6",

}

RIS

TY - JOUR

T1 - Insomnia in central neurologic diseases--occurrence and management

AU - Mayer, Geert

AU - Jennum, Poul

AU - Riemann, Dieter

AU - Dauvilliers, Yves

N1 - Copyright © 2011 Elsevier Ltd. All rights reserved.

PY - 2011

Y1 - 2011

N2 - The objective of this review is to highlight the impact of insomnia in central neurological disorders by providing information on its prevalence and give recommendations for diagnosis and treatment. Insomnia in neurological disorders is a frequent, but underestimated symptom. Its occurrence may be a direct consequence of the disease itself or may be secondary to pain, depression, other sleep disorders or the effects of medications. Insomnia can have a significant impact on the patient's cognitive and physical function and may be associated with psychological distress and depression. Diagnosis of insomnia is primarily based on medical history and validated questionnaires. Actigraphy is a helpful diagnostic tool for assessing the circadian sleep-wake rhythm. For differential diagnosis and to measure the duration of sleep full polysomnography may be recommended. Prior to initiating treatment the cause of insomnia must be clearly identified. First line treatment aims at the underlying neurologic disease. The few high quality treatment studies show that short term treatment with hypnotics may be recommended in most disorders after having ruled out high risk for adverse effects. Sedating antidepressants may be an effective treatment for insomnia in stroke and Parkinson's disease (PD) patients. Melatonin and light treatment can stabilize the sleep-wake circadian rhythm and shorten sleep latency in dementias and PD. Cognitive behavioral therapy (CBT) can be effective in treating insomnia symptoms associated with most of the central neurological diseases. The prevalence and treatment of insomnia in neurological diseases still need to be studied in larger patient groups with randomized clinical trials to a) better understand their impact and causal relationship and b) to develop and improve specific evidence-based treatment strategies.

AB - The objective of this review is to highlight the impact of insomnia in central neurological disorders by providing information on its prevalence and give recommendations for diagnosis and treatment. Insomnia in neurological disorders is a frequent, but underestimated symptom. Its occurrence may be a direct consequence of the disease itself or may be secondary to pain, depression, other sleep disorders or the effects of medications. Insomnia can have a significant impact on the patient's cognitive and physical function and may be associated with psychological distress and depression. Diagnosis of insomnia is primarily based on medical history and validated questionnaires. Actigraphy is a helpful diagnostic tool for assessing the circadian sleep-wake rhythm. For differential diagnosis and to measure the duration of sleep full polysomnography may be recommended. Prior to initiating treatment the cause of insomnia must be clearly identified. First line treatment aims at the underlying neurologic disease. The few high quality treatment studies show that short term treatment with hypnotics may be recommended in most disorders after having ruled out high risk for adverse effects. Sedating antidepressants may be an effective treatment for insomnia in stroke and Parkinson's disease (PD) patients. Melatonin and light treatment can stabilize the sleep-wake circadian rhythm and shorten sleep latency in dementias and PD. Cognitive behavioral therapy (CBT) can be effective in treating insomnia symptoms associated with most of the central neurological diseases. The prevalence and treatment of insomnia in neurological diseases still need to be studied in larger patient groups with randomized clinical trials to a) better understand their impact and causal relationship and b) to develop and improve specific evidence-based treatment strategies.

U2 - 10.1016/j.smrv.2011.01.005

DO - 10.1016/j.smrv.2011.01.005

M3 - Journal article

VL - 15

SP - 369

EP - 378

JO - Sleep Medicine Reviews

JF - Sleep Medicine Reviews

SN - 1087-0792

IS - 6

ER -

ID: 40162666